Report: US Drugmaker Focused on Profits, Not Patients
The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting...
Opposition mounts to genetic modification of human embryos
A group of U.S. scientists and activists on Monday called for a global ban on the use of new tools to edit the genes of human embryos, in...
Italian doctor working for children's charity killed in Kenya
NAIROBI (Thomson Reuters Foundation) - An Italian doctor working for a children's charity in Kenya was killed and three other Italians,...
Doctors' use of computers during appointments leaves patients less satisfied
(Reuters Health) - Doctors who entered data into computerized health records during patients' appointments did less positive...
Beijing aims to refill medicine chest with 'Made in China' drugs
China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the...
Obamacare has made young people lazier — but that's not necessarily a bad thing
Under the Affordable Care Act, young adults are allowed to stay on their parents' health insurance up to age 26. Since people generally...
The Pfizer-Allergan Deal is a Tax Inversion
Pfizer just struck the largest-ever takeover by a drugmaker, a $160 billion merger with Allergan. In addition to best-selling cosmetic...
Pfizer Said Near Agreement to Buy Allergan in Biggerst Deal
Pfizer Inc. is in advanced talks to buy Botox maker Allergan Plc for as much as $380 per share, according to people familiar with the...
